TP53 and hepatocellular carcinoma: The results revealed that patients with multiple tumors or HCC accompanied by metastasis exhibited significantly higher mutation frequencies in TP53, RET, APC, and FGFR3 compared to those with single tumors, suggesting that these mutations are closely associated with HCC metastasis [139].